Get Pembrolizumab Head And Neck Cancer Nejm UK. Pembrolizumab alone and combined with chemotherapy is a more efficacious first line treatment for recurrent head and neck cancer than the research was led by the institute of cancer research (icr), london and the royal marsden nhs foundation trust, but carried out across 206 sites. Head and neck cancers comprise the sixth most common cancer type in the united states with estimated 14,620 deaths in 2019.
If you have symptoms of a head or neck cancer or your doctor finds anything strange at your yearly exam, you might have to get a few tests.
Based on the results of the new clinical trial, pembrolizumab looks set to do the same for people diagnosed with recurrent head and neck cancer. Results from the phase ib. Head and neck cancer (hnc) is a heterogeneous group of squamous cell cancers that affect the oral cavity, pharynx, and larynx. Keytruda may be used alone when your head and neck cancer has spread or returned, and you have received chemotherapy that contains platinum and it did not work or.